biomaterials access assurance act united states federal statute establishing liability exemptions biomaterial suppliers selling chemical components raw materials utilized implantable devices human recipients united states federal legislation sets forth rules limiting litigation costs unwarranted lawsuits biomaterial suppliers excluded design production testing implantable devices demonstrated effective safe include adequate product warnings hr bill passed united states congressional session enacted law president united states bill clinton august act compiled six sections establishing liability rulings biomaterial elements sold domestic international suppliers healthcare manufacturers located continental united states january united states house representatives united states senate introduced initial liability exemption legislation suppliers dealing biomaterial bulk